Clinical Cancer Research Targets AACR Membership
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Clinical Cancer Research 14, 6405, October 15, 2008. doi: 10.1158/1078-0432.CCR-08-0816
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CCR Translation on this Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Conti, J. A.
Right arrow Articles by Iredale, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Conti, J. A.
Right arrow Articles by Iredale, J. P.
Related Collections
Right arrowCommentary

Human Cancer Biology

The Desmoplastic Reaction Surrounding Hepatic Colorectal Adenocarcinoma Metastases Aids Tumor Growth and Survival via {alpha}v Integrin Ligation

John A. Conti1,2, Timothy J. Kendall1,3, Adrian Bateman3, Thomas A. Armstrong1, Andrew Papa-Adams2, Qian Xu1, Graham Packham2, John N. Primrose2, R. Christopher Benyon1 and John P. Iredale4

Authors' Affiliations: 1 Liver and Pancreas Research Group, Infection, Inflammation and Repair Division and 2 Cancer Sciences Division, University of Southampton; 3 Histopathology Department, Southampton General Hospital, Southampton, United Kingdom; and 4 Centre for Inflammation Repair, University of Edinburgh, Queen's Medical Research Institute, Edinburgh, United Kingdom

Requests for reprints: John A. Conti, Infection, Inflammation and Repair Division, Southampton University, E Level, South Block, Southampton General Hospital, Mailpoint 811, Tremona Road, Southampton SO16 6YD, United Kingdom. Phone: 44-2380796144; E-mail: jaconti1{at}soton.ac.uk.

Purpose: The treatment of metastatic colorectal carcinoma represents a major clinical challenge. We investigated the hypothesis that the desmoplastic reaction within the liver elicited by metastatic adenocarcinoma, characterized by collagen I deposition and altered collagen IV distribution, promotes the growth and survival of hepatic colorectal carcinoma metastases.

Experimental Design: Partial hepatectomy specimens for metastatic colorectal adenocarcinoma were examined immunohistochemically for differential integrin expression. Human colorectal adenocarcinoma cell lines HT-29, KM12SM, and KM12c were grown on wild-type collagen I or IV, or cleavage-resistant r/r collagen I, and assessed for their growth, survival, and resistance to 5-fluorouracil. The effect of {alpha}vβ3 and {alpha}vβ5 integrin blockade by neutralizing antibodies was examined.

Results: Collagen I, in contrast to collagen IV, significantly enhanced the growth, survival, and chemoresistance of colorectal carcinoma cells. Blockade of the {alpha}vβ3 and {alpha}vβ5 integrins significantly reduced colorectal carcinoma cell proliferation on collagen, especially in the cell line with the most metastatic potential. These in vitro findings correlated with the pattern of integrin expression identified within resected hepatic colorectal carcinoma metastases. Using matrix metalloproteinase-resistant r/r collagen I as a dominant negative ligand for {alpha}v integrins, we showed a key role for this integrin-ligand interaction in mediating the survival and proliferation of colorectal carcinoma cells.

Conclusions: Desmoplasia has an important role in the development of hepatic colorectal carcinoma metastasis. The interaction between integrin and collagen I is identified as a potential therapeutic target.


Commentary

{alpha}v Integrins Lead the Way for Colorectal Metastases
Joseph H. McCarty
Clin. Cancer Res. 2008 14: 6351-6353. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
J. H. McCarty
{alpha}v Integrins Lead the Way for Colorectal Metastases
Clin. Cancer Res., October 15, 2008; 14(20): 6351 - 6353.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2008 by the American Association for Cancer Research.